🇺🇸 ASTRAZENECA PLCAZN
Get ASTRAZENECA PLC filings on Telegram the moment they are published.
Follow ASTRAZENECA PLC on TelegramOne tap starts your 30-day free trial. No card needed.
Subject: 6-K — Foreign issuer report
Overview: FDA granted accelerated approval for Ultomiris to reduce proteinuria in adults with primary immunoglobulin A nephropathy based on I CAN Phase III results.
Source: SEC EDGAR · Original filing
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest